semaglutide and hfpef versus placebo in patients with heart failure mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials Semaglutide versus placebo in people

11,16,17 Therefore, answer A is true

Nat Reviews Chem 6(7):451469

Never change doses without professional guidance

However, these strategies often fail to offer sustainable solutions, as the body's powerful biological mechanisms fight to regain lost weight

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF